Article
Hydroxylation of antitubercular drug candidate, SQ109, by mycobacterial cytochrome P450
2020-08-27
Abstract excerpt
Spreading of the multidrug-resistant (MDR) strains of the deadliest pathogen Mycobacterium tuberculosis (Mtb) generates the need for new effective drugs. SQ109 showed activity against resistant Mtb and already advanced to Phase II/III clinical trials. Fast SQ109 degradation is attributed to the human liver Cytochrome P450s (CYPs). However, no information is available about interactions of the drug with Mtb CYPs....
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ee9727d2-b683-55ad-9d27-477a8133c29a
- DOI
- 10.1101/2020.08.27.269936
